A carregar...

Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients

INTRODUCTION: By targeting different subtypes of 5-hydroxytryptamine (5HT) receptors in the gastrointestinal (GI) tract, several drugs have been introduced for the management of irritable bowel syndrome (IBS). Renzapride is a full agonist for 5HT4 receptor and an antagonist to 5HT2b and 5HT3 recepto...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3953973/
https://ncbi.nlm.nih.gov/pubmed/24701208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2014.40729
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!